Moderna to increase doses per vial as U.S. COVID-19 vaccination ramps up

Fundamentals Moderna

For this year the company from Cambridge could earn a total revenue around 518.85 million USD. This is according to the average of the analysts' estimates. This is hugely more than 2019's revenue of 60.21 million USD.

Historical revenues and results Moderna Inc plus estimates 2020

The analysts expect for 2020 a net loss of 568 million USD. For this year the consensus of the result per share is a loss of 1.55 USD. The PE-ratio therefore is -101.6.

For this year analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies is a low 0.11 percent.

Based on the current number of outstanding shares Moderna Inc 's market capitalization 51.78 billion USD. The Moderna Inc stock was the past 12 months quite unstable. Since last February the stock is even 673 percent higher. This year the stock price moved between 18 and 186 dollar.

Historical stock prices Moderna Inc period 2007-2020

Click here for dividend Moderna Inc. At 21.44 the stock trades 0.54 percent higher at 157.48 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.